PAMELA WRIGHT: Open Payments
NPI 1164739751 · STUART, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 27 payments from 14 companies in 2025. Trend: 2023 $551 · 2024 $364 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $114 |
| PFIZER INC. | 4 | $75 |
| ABBVIE INC. | 4 | $68 |
| Novo Nordisk Inc | 3 | $54 |
| Amgen Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Medtronic, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: DUPIXENT, NURTEC ODT, VRAYLAR, ELIQUIS, INGREZZA, QULIPTA, OTEZLA, Wegovy.
Industry payments across VA — which companies pay providers there.
